Controversial Diabetes Drug May Stay On MarketJuly 16, 2010 | Kathryn MobleyThe FDA is considering a recommendation to keep a controversial diabetes drug on the market. WFDD's Kathryn Mobley spoke with one Winston-Salem doctor who is closely involved with this issue.
|
Headlines for June 7, 2010
|